Corcept Therapeutics
CORT
#2201
Rank
A$12.62 B
Marketcap
A$117.62
Share price
-0.41%
Change (1 day)
7.41%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: A$12.62 Billion

As of June 2026 Corcept Therapeutics has a market cap of A$12.62 Billion. This makes Corcept Therapeutics the world's 2201th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$12.62 B-2.89%
2025A$13.00 B47.11%
2024A$8.83 B79.85%
2023A$4.91 B52.95%
2022A$3.21 B1.9%
2021A$3.15 B-20.22%
2020A$3.95 B99.65%
2019A$1.97 B-9.25%
2018A$2.18 B-17.37%
2017A$2.64 B136.08%
2016A$1.11 B49.2%
2015A$0.74 B101.65%
2014A$0.37 B3.44%
2013A$0.35 B161.62%
2012A$0.13 B-51.11%
2011A$0.28 B2.11%
2010A$0.27 B42.31%
2009A$0.19 B168.74%
2008A$71.94 M-48.53%
2007A$0.13 B248.13%
2006A$40.15 M-64.45%
2005A$0.11 B-38.24%
2004A$0.18 B

End of Day market cap according to different sources

On Jun 12th, 2026 the market cap of Corcept Therapeutics was reported to be:

A$12.62 Billion
by Nasdaq info icon info icon
A$12.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$822.59 B 6,414.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$414.36 B 3,181.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$211.92 B 1,578.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.433 T 11,251.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$417.14 B 3,203.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$165.51 B 1,210.75%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$1.60 B-87.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.15 B-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.34 B 21.50%๐Ÿ‡บ๐Ÿ‡ธ USA